Pharmaceutical
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (FY2026)
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2026 (FY2026)
About this update from Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co., Ltd. (4574) Press ReleaseView Attachment
View stock analysis, news, and events for Taiko Pharmaceutical Co., Ltd.